Search Orphan Drug Designations and Approvals
-
Generic Name: | L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser |
---|---|
Date Designated: | 09/13/2011 |
Orphan Designation: | Treatment of neuropathic pain in patients with sarcoidosis. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Araim Pharmaceuticals, Inc. 712 Kitchawan Raod Ossining, New York 10562 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-